Stimatix GI

Company Overview

Snapshot

Founded in June 2009 by Yaron Daniel Raiter, Stimatix GI operated with 1–10 employees. The company secured funding across two rounds from two investors, with Pontifax participating in one round. Stimatix GI was acquired by B. Braun Medical SAS in April 2018.

Business overview

Stimatix GI develops stomal management solutions, focusing on improving the quality of life for individuals with stomas. The company's core product line, the artificial ostomy sphincter (AOS) series, includes devices like the AOS-C2000, designed to provide improved bowel-content control and management. These products aim to restore continence and minimize physical discomfort associated with ostomy care, serving patients in the Health Tech & Life Sciences sector, specifically within Medical Devices and Medical Treatment & Therapeutics.

Strategic signal

In April 2018, Stimatix GI was acquired by B. Braun Medical SAS. This acquisition signals a strategic validation of Stimatix GI's artificial ostomy sphincter technology and its potential to address unmet needs in stomal management, integrating its innovative solutions into a larger medical device portfolio.

Company Intelligence Q&A

When was Stimatix GI acquired?

Stimatix GI was acquired by B. Braun Medical SAS in April 2018.

What was a notable recognition for Stimatix GI in 2012?

Stimatix GI was named Best Start-up Company of 2012 by Israel's Office of the Chief Scientist in August 2012.

What is the primary focus of Stimatix GI's products?

Stimatix GI focuses on developing artificial ostomy sphincter devices, such as the AOS-C2000, to provide improved bowel-content control and management for people with stomas.

When was Stimatix GI founded?

Stimatix GI was founded in June 2009.